Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 723-733 , December 2009

Lithium and thyroid

  • John H. Lazarus, MA, MD, FRCP, FACE, FRCOG (Professor of Clinical Endocrinology)

      Affiliations

    • Corresponding Author InformationTel./Fax: +44 2920 744326.

References 

  1. Schou M, Amdisen A, Jensen S, et al. Occurrence of goitre during lithium treatment. British Medical Journal. 1968;iii:710–713
  2. Williams JA, Berens SC, Wolff J. Thyroid secretion in vitro: inhibition of TSH and dibutyryl cyclic-AMP stimulated 131-I release by Li+1. Endocrinology. 1971;88:1385–1388
  3. Lazarus JH. Lithium and the thyroid gland. In:  Lazarus JH editors. Endocrine and metabolic effects of lithium. New York and London: Plenum Medical Book Company; 1986;p. 99–124
  4. Chow CC, Cockram CS. Thyroid disorders induced by lithium and amiodarone: an overview. Adverse Drug Reactions and Acute Poisoning Reviews. 1990;4:207–222
  5. Kushner JP, Wartofsky L. Lithium-thyroid interactions. An overview. In:  Johnnson NF editors. Lithium and the Endocrine System. Lancaster: Karger; 1998;p. 74–88
  6. Lazarus JH. Effect of lithium on the thyroid gland. In:  Weetman AP,  Grossman A editor. Pharmacotherapeutics of the thyroid gland. Berlin, Germany: Springer-Verlag; 1997;p. 207–218
  7. Lazarus JH, Kirov G, Harris BB. Effects of lithium on thyroid and endocrine glands. In:  Bauer M,  Grof P,  Muller-Oerlingausen B editor. Lithium in neuropsychiatry. London UK: Taylor & Francis; 2006;p. 259–270
  8. Berens SC, Wolff J, Murphy DL. Lithium concentration by the thyroid. Endocrinology. 1970;87:1085–1087
  9. Eskandari S, Loo DD, Dai G, et al. Thyroid Na+ I− symporter. Mechanism, stoichiometry, and specificity. The Journal of Biological Chemistry. 1997;272:27230–27238
  10. Spaulding SW, Burrow G, Bermudez F, et al. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. The Journal of Clinical Endocrinology and Metabolism. 1972;35:905–911
  11. Bianco AC, Larsen PR. Intracellular pathways of iodothyronine metabolism. In:  Braverman LE,  Utiger RD editor. Werner and Ingbar's the thyroid a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 109–133
  12. St Germain DL. Thyroid hormone metabolism. In:  Johnson NF editors. Lithium and the endocrine system. Lancaster: Karger; 1988;p. 123–133
  13. Terao T, Oga T, Nozaki S, et al. Possible inhibitory effect of lithium on peripheral conversion of thyroxine to triiodothyronine – a prospective study. International Clinical Psychopharmacology. 1995;10:103–105
  14. Baumgartner A, Campos-Barros A, Gaio U, et al. Effects of lithium on thyroid hormone metabolism in rat frontal-cortex. Biological Psychiatry. 1994;36:771–774
  15. Baumgartner A, Pinna G, Hiedra L, et al. Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology. 1997;1:25–41
  16. Eravci M, Pinna G, Meinhold H, et al. Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology. 2000;141:1027–1040
  17. Pinna G, Broedel O, Eravci M, et al. Thyroid hormones in the rate amygdale as common targets for antidepressant drugs, mood stabilizers and sleep deprivation. Biological Psychiatry. 2003;54:1049–1059
  18. Pfeifer WD, Davis LC, Van der Velde CD. Lithium accumulation in some endocrine tissues. Acta biologica et medica Germanica. 1976;35:1519–1523
  19. Lazarus JH, John R, Bennie EH, et al. Lithium therapy and thyroid function a long-term study. Psychological Medicine. 1981;11:85–92
  20. Lomabardi G, Panza N, Biondi L, et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis – a longitudinal study. Journal of Endocrinological Investigation. 1993;16:259–263
  21. Gyulai L, Lauer M, Bauer MS, et al. Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge. Biological Psychiatry. 2003;53:899–905
  22. Baumgartner A, Vonstuckrad M, Mulleroerlinghausen B, et al. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years – high triiodothyronine serum concentrations are correlated to the prophylactic efficacy. Journal of Affective Disorders. 1995;34:211–218
  23. Bolaris S, Margarity M, Valcana T. Effects of LiCl on triiodothyronin (T3) binding to nuclei from rat cerebral hemispheres. Biological Psychiatry. 1995;37:106–111
  24. Hahn CG, Pawlyk AC, Whybrow PC, et al. Differential expression of thyroid hormone receptor isoforms by thyroid hormone and lithium in rat GH3 and B103 cells. Biological Psychiatry. 1999;45:1004–1012
  25. Hahn CG, Pawlyk AC, Whybrow PC, et al. Lithium administration affects gene expression of thyroid hormone receptors in rat brain. Life Sciences. 1999;64:1793–1802
  26. Constantiou C, Bolaris S, Valcana T, et al. Acute LiCl-treatment affects the cytoplasmic T4 availability and the expression pattern of thyroid hormone receptors in adult rat cerebral hemispheres. Neuroscience Research. 2004;51:235–241
  27. Takano T, Takada K, Tada H, et al. Genistein but not staurosporine can inhibit the mitogenic signal evoked by lithium in rat-thyroid cells (FRTL-5). The Journal of endocrinology. 1994;143:221–226
  28. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:8455–8459
  29. Hedgepeth CM, Conrad LJ, Zhang J, et al. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Developmental Biology. 1997;185:82–91
  30. Rao AS, Kremenevskaja N, Resch J, et al. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. European Journal of Endocrinology. 2005;153:929–938
  31. Perrild H, Hegedus L, Arnung K. Sex related goitrogenic effect of lithium carbonate in healthy young subjects. Acta Endocrinologica. 1984;106:203–208
  32. Heltne CE, Ollerich DA. Morphometric and electron microscopic studies of goitre induced by lithium in the rat. The American Journal of Anatomy. 1973;136:297
  33. Fauerholdt L, Vvendsborg P. Thyroid gland morphology after lithium treatment. Acta Pathologica et Microbiologica Scandinavica. 1981;89:339–341
  34. Wolff J. Lithium interactions with the thyroid gland. In:  Cooper TB,  Gershon S,  Kline NS editor. Lithium controversies and unresolved issues. Amsterdam: Excerpta Medica; 1978;p. 552–564
  35. Mannisto PT. Endocrine side-effects of lithium. In:  Johnson FN editors. Handbook of lithium therapy. Lancaster: MTP Press; 1980;p. 310–322
  36. Lazarus JH, Bennie EH. The effect of lithium on thyroid function in man. Acta Endocrinologica. 1972;70:266–272
  37. Perrild H, Hegedus L, Baastrup PC, et al. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. The American Journal of Psychiatry. 1990;147:1518–1520
  38. Bauer M, Blumentritt H, Finke R, et al. Using ultrasonography to determine thyroid size and prevalence of goitre in lithium-treated patients with affective disorders. Journal of Affective Disorders. 2007;104:35–51
  39. Ozpoyraz N, Tamam L, Kulan E. Thyroid abnormalities in lithium treated patients. Advances in Therapy. 2002;19:176–184
  40. Caykoylu A, Capoglu I, Unuyvar N, et al. Thyroid abnormalities in lithium-treated patients with bipolar affective disorder. The Journal of International Medical Research. 2002;30:80–84
  41. Schiemann U, Hengst K. Thyroid echogenicity in manic-depressive patients receiving lithium therapy. Journal of Affective Disorders. 2002;70:85–90
  42. Talwar N, Mohan S, Ravi B, et al. Lithium-induced enlargement of a lingual thyroid. Singapore Medical Journal. 2008;49:254–255
  43. Rogers M, Whybrow P. Clinical hypothyroidism occurring during lithium treatment. Two case histories and a review of thyroid function in 19 patients. The American Journal of Psychiatry. 1971;128:50–55
  44. Waldman SA, Park D. Myxedema coma associated with lithium therapy. The American Journal of Medicine. 1989;87:355–356
  45. Phillips BD, Gopalakrishnan G, Gohh R, et al. Lithium toxicity precipitated by profound hypothyroidism. Thyroid. 2008;18:651–654
  46. Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1–30 years. Acta Psychiatrica Scandinavica. 1995;91:48–51
  47. Kirov G. Thyroid disorders in lithium-treated patients. Journal of Affective Disorders. 1998;50:33–40
  48. Deodhar SD, Singh B, Pathak CM, et al. Thyroid functions in lithium-treated psychiatric patients: a cross-sectional study. Biological Trace Element Research. 1999;67:151–163
  49. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. Journal of Psychiatry & Neuroscience. 1999;24:227–233
  50. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. The British Journal of Psychiatry. 1999;175:336–339
  51. Gracious BL, Findling RL, Seman C, et al. Elevated thyrotropin in bipolar youths prescribed both lithium and divalproex sodium. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:215–220
  52. Kirov G, Tredget J, John R, et al. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. Journal of Affective Disorders. 2005;87:313–317
  53. Aliasgharpour M, Abbassi M, Shafaroodi H, et al. Subclinical hypothyroidism in lithium-treated psychiatric patients in Tehran, Islamic Republic of Iran. Eastern Mediterranean Health Journal. 2005;11:329–333
  54. Fagolini A, Kupfer DJ, Scott J, et al. Hypothyroidism in patients with bipolar disorder treated primarily with lithium. Epidemiologia e Psichiatria Sociale. 2006;15:123–127
  55. Bocchetta A, Cocco F, Velluzzi F, et al. Fifteen-year follow-up of thyroid function in lithium patients. Journal of Endocrinological Investigation. 2007;30:363–366
  56. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clinical Endocrinology. 1995;43:55–68
  57. Lazarus JH, Ludgate M, McGregor A, et al. Lithium therapy induces autoimmune thyroid disease. In:  Walfish PG,  Wall JR,  Volpe R editor. Autoimmunity and the thyroid. London: Academic Press; 1985;p. 319–320
  58. Bathge C, Blimentritt H, Berghofer A, et al. Long term lithium and thyroid antibodies: a controlled study. Journal of Psychiatry & Neuroscience. 2005;30:423–427
  59. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment – a 2-year follow-up study. Acta Psychiatrica Scandinavica. 1992;86:38–41
  60. Bocchetta A, Mossa P, Velluzzi F, et al. Ten-year follow-up of thyroid function in lithium patients. Journal of Clinical Psychopharmacology. 2001;21:594–598
  61. Ahmadi-Abhari A, Ghaeli P, Fahimi F, et al. Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry. 2003;3:4
  62. Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biological Psychiatry. 2002;51:305–311
  63. Shopsin B, Shenkman L, Blum M, et al. Iodine and lithium-induced hypothyroidism. Documentation of synergism. The American Journal of Medicine. 1973;55:695–699
  64. Lee S, Chow CC, Wing YK, et al. Thyroid abnormalities during chronic lithium treatment in Hong-Kong Chinese – a controlled study. Journal of Affective Disorders. 1992;26:173–178
  65. Shulman KI, Sykora K, Gill SS. New thyroxine treatment in older adults beginning lithium therapy. The American Journal of Geriatric Psychiatry. 2005;13:299–304
  66. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. The Journal of the American Medical Association. 2004;291:228–238
  67. Kleiner J, Altshuler L, Hendrick V, et al. Lithium-induced sublinical hypothyroidism: review of the literature and guidelines for treatment. The Journal of Clinical Psychiatry. 1990;60:249–255
  68. Barclay ML, Brownlie BEW, Turner JG, et al. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clinical Endocrinology. 1994;40:759–764
  69. Sinnott MJ, McIntyre HD, Pond SM. Granulomatous thyroiditis and lithium therapy. Australian and New Zealand Journal of Medicine. 1992;22:84
  70. Mizukami Y, Michigishi T, Nonomura A, et al. Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis. Journal of Clinical Pathology. 1995;48:582–584
  71. Miller KK, Daniels GH. Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clinical Endocrinology. 2001;55:501–508
  72. Law A, Rifkind J, Rosen F, et al. Hyperthyroidism six years post- BMT for acute myeloblastic leakemia in a patient on long-term lithium therapy for bipolar affective disorder. Leukemia & Lymphoma. 2004;45:807–809
  73. Segal RL, Rosenblatt S, Eliasoph I. Endocrine exophthalmos during lithium therapy of manic depressive disease. The New England Journal of Medicine. 1973;289:136–138
  74. Byrne AP, Delaney WJ. Regression of thyrotoxic ophthalmopathy following lithium withdrawal. Canadian Journal of Psychiatry. 1993;38:383–390
  75. Temple R, Berman M, Robbins J, et al. The use of lithium in the treatment of thyrotoxicosis. The Journal of Clinical Investigation. 1972;51:2746–2756
  76. Lazarus JH, Richards AR, Addison GM, et al. Treatment of thyrotoxicosis with lithium carbonate. Lancet. 1974;16:1160–1163
  77. Kristensen O, Andersen HH, Pallisgaard G. Lithium carbonate in the treatment of thyrotoxicosis. A controlled trial. Lancet. 1976;20:603–605
  78. Ng YW, Tiu SC, Choi KL, et al. Use of lithium in the treatment of thyrotoxicosis. Hong Kong Medical Journal. 2006;12:254–259
  79. Turner JG, Brownlie BE, Rogers TG. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis. Lancet. 1976;20:614–615
  80. Bogazzi F, Bartalena L, Brogioni S, et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. The Journal of Clinical Endocrinology and Metabolism. 1999;84:499–503
  81. Bogazzi F, Bartalena L, Campomori A, et al. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. The Journal of Clinical Endocrinology and Metabolism. 2002;87:4490–4495
  82. Bal CS, Kumar A, Pandey RM. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid. 2002;12:399–405
  83. Dunkelmann S, Künstner H, Nabavi E, et al. Lithium as an adjunct to radioiodine therapy in Graves' disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not?. Nuklearmedizin. 2006;45:213–218
  84. Vannucchi G, Chiti A, Mannavola D, et al. Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium. European Journal of Nuclear Medicine and Molecular Imaging. 2005;32:1081–1088
  85. Dunkelmann S, Künstner H, Nabavi E, et al. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 1999;84:912–916
  86. Liu YY, van der Pluijm G, Karperien M, et al. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies. Clinical Endocrinology. 2006;64:617–624

PII: S1521-690X(09)00072-4

doi: 10.1016/j.beem.2009.06.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 723-733 , December 2009

Article Tools

* Image Usage & Resolution